Citius Oncology, Inc. CTOR Payment For Other Invoice And Accumulated Interest
Payment For Other Invoice And Accumulated Interest at other companies
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept ctor:PaymentForOtherInvoiceAndAccumulatedInterest.
The official record: Citius Oncology, Inc.’s 10-K, filed December 23, 2025, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s payment for other invoice and accumulated interest.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Citius Oncology, Inc.'s payment for other invoice and accumulated interest?
- Citius Oncology, Inc. (CTOR) reported payment for other invoice and accumulated interest of $1.62M in Q3 2025.
- What does payment for other invoice and accumulated interest mean?
- Represents cash outflows for the settlement of outstanding invoices and any associated accrued interest charges. This metric provides insight into the company's working capital management and its ability to meet short-term financial obligations. Consistent monitoring helps identify potential liquidity issues or delays in vendor payments.